tiprankstipranks
4D Molecular Therapeutics (FDMT)
NASDAQ:FDMT
US Market
FDMT
4D Molecular Therapeutics
RESEARCH TOOLSreports
Want to see FDMT full AI Analyst Report?

4D Molecular Therapeutics (FDMT) Financial Statements

516 Followers

4D Molecular Therapeutics Financial Overview

4D Molecular Therapeutics's market cap is currently $463.68M. The company's EPS TTM is $0.43; its P/E ratio is -3.10; 4D Molecular Therapeutics is scheduled to report earnings on March 18, 2026, and the estimated EPS forecast is $-1.00. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 85.21M$ 37.00K$ 20.72M$ 3.13M$ 18.04M
Gross Profit$ 77.58M$ 37.00K$ -76.37M$ -77.12M$ -43.32M
Operating Income$ -159.55M$ -187.84M$ -112.87M$ -110.03M$ -71.33M
EBITDA$ -151.92M$ -181.14M$ -108.66M$ -107.63M$ -69.81M
Net Income$ -140.11M$ -160.87M$ -100.84M$ -107.49M$ -71.32M
Balance Sheet
Cash & Short-Term Investments$ 402.65M$ 424.88M$ 288.23M$ 213.55M$ 247.78M
Total Assets$ 566.71M$ 560.38M$ 339.89M$ 261.85M$ 353.49M
Total Debt$ 21.41M$ 24.61M$ 14.67M$ 16.12M$ 16.45M
Net Debt$ -38.83M$ -124.73M$ -234.44M$ -36.23M$ -136.55M
Total Liabilities$ 61.05M$ 49.78M$ 32.06M$ 30.51M$ 34.38M
Stockholders' Equity$ 505.66M$ 510.61M$ 307.83M$ 231.34M$ 319.11M
Cash Flow
Free Cash Flow$ -109.08M$ -138.37M$ -78.56M$ -98.22M$ -78.24M
Operating Cash Flow$ -109.08M$ -134.59M$ -75.79M$ -86.69M$ -69.13M
Investing Cash Flow$ -92.97M$ -302.44M$ 115.72M$ -17.05M$ -172.68M
Financing Cash Flow$ 112.96M$ 337.25M$ 156.83M$ 3.08M$ 118.09M
Currency in USD

4D Molecular Therapeutics Earnings and Revenue History

Income Statement >

4D Molecular Therapeutics Debt to Assets

Balance Sheet >

4D Molecular Therapeutics Cash Flow

Cash Flow >

4D Molecular Therapeutics Forecast EPS vs Actual EPS

Earnings >